181 related articles for article (PubMed ID: 33203900)
21. A new XPC gene splicing mutation has lead to the highest worldwide prevalence of xeroderma pigmentosum in black Mahori patients.
Cartault F; Nava C; Malbrunot AC; Munier P; Hebert JC; N'guyen P; Djeridi N; Pariaud P; Pariaud J; Dupuy A; Austerlitz F; Sarasin A
DNA Repair (Amst); 2011 Jun; 10(6):577-85. PubMed ID: 21482201
[TBL] [Abstract][Full Text] [Related]
22. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C.
Giglia G; Dumaz N; Drougard C; Avril MF; Daya-Grosjean L; Sarasin A
Cancer Res; 1998 Oct; 58(19):4402-9. PubMed ID: 9766670
[TBL] [Abstract][Full Text] [Related]
23. Why Cockayne syndrome patients do not get cancer despite their DNA repair deficiency.
Reid-Bayliss KS; Arron ST; Loeb LA; Bezrookove V; Cleaver JE
Proc Natl Acad Sci U S A; 2016 Sep; 113(36):10151-6. PubMed ID: 27543334
[TBL] [Abstract][Full Text] [Related]
24. A unique chromosomal in-frame deletion identified among seven XP-C patients.
Schubert S; Rieper P; Ohlenbusch A; Seebode C; Lehmann J; Gratchev A; Emmert S
Photodermatol Photoimmunol Photomed; 2016 Sep; 32(5-6):276-283. PubMed ID: 27387384
[TBL] [Abstract][Full Text] [Related]
25. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum.
Pawsey SA; Magnus IA; Ramsay CA; Benson PF; Giannelli F
Q J Med; 1979 Apr; 48(190):179-210. PubMed ID: 504548
[TBL] [Abstract][Full Text] [Related]
26. Mutations in the XPD gene in xeroderma pigmentosum group D cell strains: confirmation of genotype-phenotype correlation.
Kobayashi T; Uchiyama M; Fukuro S; Tanaka K
Am J Med Genet; 2002 Jul; 110(3):248-52. PubMed ID: 12116233
[TBL] [Abstract][Full Text] [Related]
27. A mutation in the XPB/ERCC3 DNA repair transcription gene, associated with trichothiodystrophy.
Weeda G; Eveno E; Donker I; Vermeulen W; Chevallier-Lagente O; Taïeb A; Stary A; Hoeijmakers JH; Mezzina M; Sarasin A
Am J Hum Genet; 1997 Feb; 60(2):320-9. PubMed ID: 9012405
[TBL] [Abstract][Full Text] [Related]
28. True XP group E patients have a defective UV-damaged DNA binding protein complex and mutations in DDB2 which reveal the functional domains of its p48 product.
Rapić-Otrin V; Navazza V; Nardo T; Botta E; McLenigan M; Bisi DC; Levine AS; Stefanini M
Hum Mol Genet; 2003 Jul; 12(13):1507-22. PubMed ID: 12812979
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of matrix metalloproteinase 1 in dermal fibroblasts from DNA repair-deficient/cancer-prone xeroderma pigmentosum group C patients.
Fréchet M; Warrick E; Vioux C; Chevallier O; Spatz A; Benhamou S; Sarasin A; Bernerd F; Magnaldo T
Oncogene; 2008 Sep; 27(39):5223-32. PubMed ID: 18469853
[TBL] [Abstract][Full Text] [Related]
30. Two individuals with features of both xeroderma pigmentosum and trichothiodystrophy highlight the complexity of the clinical outcomes of mutations in the XPD gene.
Broughton BC; Berneburg M; Fawcett H; Taylor EM; Arlett CF; Nardo T; Stefanini M; Menefee E; Price VH; Queille S; Sarasin A; Bohnert E; Krutmann J; Davidson R; Kraemer KH; Lehmann AR
Hum Mol Genet; 2001 Oct; 10(22):2539-47. PubMed ID: 11709541
[TBL] [Abstract][Full Text] [Related]
31. Characterization of molecular defects in xeroderma pigmentosum group C.
Li L; Bales ES; Peterson CA; Legerski RJ
Nat Genet; 1993 Dec; 5(4):413-7. PubMed ID: 8298653
[TBL] [Abstract][Full Text] [Related]
32. Retrovirus-mediated gene transfer corrects DNA repair defect of xeroderma pigmentosum cells of complementation groups A, B and C.
Zeng L; Quilliet X; Chevallier-Lagente O; Eveno E; Sarasin A; Mezzina M
Gene Ther; 1997 Oct; 4(10):1077-84. PubMed ID: 9415314
[TBL] [Abstract][Full Text] [Related]
33. Functional retroviral vector for gene therapy of xeroderma pigmentosum group D patients.
Carreau M; Quilliet X; Eveno E; Salvetti A; Danos O; Heard JM; Mezzina M; Sarasin A
Hum Gene Ther; 1995 Oct; 6(10):1307-15. PubMed ID: 8590735
[TBL] [Abstract][Full Text] [Related]
34. Targeted gene therapy of xeroderma pigmentosum cells using meganuclease and TALEN™.
Dupuy A; Valton J; Leduc S; Armier J; Galetto R; Gouble A; Lebuhotel C; Stary A; Pâques F; Duchateau P; Sarasin A; Daboussi F
PLoS One; 2013; 8(11):e78678. PubMed ID: 24236034
[TBL] [Abstract][Full Text] [Related]
35. DNA damage and gene therapy of xeroderma pigmentosum, a human DNA repair-deficient disease.
Dupuy A; Sarasin A
Mutat Res; 2015 Jun; 776():2-8. PubMed ID: 26255934
[TBL] [Abstract][Full Text] [Related]
36. UV-induced skin carcinogenesis in xeroderma pigmentosum group A (XPA) gene-knockout mice with nucleotide excision repair-deficiency.
Tanaka K; Kamiuchi S; Ren Y; Yonemasu R; Ichikawa M; Murai H; Yoshino M; Takeuchi S; Saijo M; Nakatsu Y; Miyauchi-Hashimoto H; Horio T
Mutat Res; 2001 Jun; 477(1-2):31-40. PubMed ID: 11376684
[TBL] [Abstract][Full Text] [Related]
37. Attenuated XPC expression is not associated with impaired DNA repair in bladder cancer.
Naipal KA; Raams A; Bruens ST; Brandsma I; Verkaik NS; Jaspers NG; Hoeijmakers JH; van Leenders GJ; Pothof J; Kanaar R; Boormans J; van Gent DC
PLoS One; 2015; 10(4):e0126029. PubMed ID: 25927440
[TBL] [Abstract][Full Text] [Related]
38. Reconstruction of DNA repair-deficient xeroderma pigmentosum skin in vitro: a model to study hypersensitivity to UV light.
Bernerd F; Asselineau D; Frechet M; Sarasin A; Magnaldo T
Photochem Photobiol; 2005; 81(1):19-24. PubMed ID: 15369409
[TBL] [Abstract][Full Text] [Related]
39. Dissection of the molecular defects caused by pathogenic mutations in the DNA repair factor XPC.
Bernardes de Jesus BM; Bjørås M; Coin F; Egly JM
Mol Cell Biol; 2008 Dec; 28(23):7225-35. PubMed ID: 18809580
[TBL] [Abstract][Full Text] [Related]
40. Clinical heterogeneity within xeroderma pigmentosum associated with mutations in the DNA repair and transcription gene ERCC3.
Vermeulen W; Scott RJ; Rodgers S; Müller HJ; Cole J; Arlett CF; Kleijer WJ; Bootsma D; Hoeijmakers JH; Weeda G
Am J Hum Genet; 1994 Feb; 54(2):191-200. PubMed ID: 8304337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
